According to a study recently published in the Journal of the American Medical Association, the use of inferior vena cava (IVC) filters among patients with severe pulmonary embolism (PE) provides no additional health benefits over using anticoagulant medications alone—and may cause additional seriou
On July 27, 2015, a North Dakota couple filed a new Zofran lawsuit on behalf of their son, a minor. The case is currently pending in the U.S. District Court for the District of North Dakota. According to their complaint, after the mother took Zofran…
In July 2015, GlaxoSmithKline (GSK) filed a motion to consolidate all federal Zofran lawsuits in the U.S. District Court for the Eastern District of Pennsylvania. They noted that the cases had similar common questions of fact, and that consolidation would help establish consistent standards for…
Patients who have type 2 diabetes strive to keep their blood sugar levels under control for many health reasons, but particularly to protect their blood vessels. Cardiovascular disease is the number-one killer for those with diabetes, so doctors are often very focused on helping patients…
The number of men filing lawsuits against manufacturers of testosterone replacement drugs continues to climb. These manufacturers, the plaintiffs claim, failed to provide adequate warnings about the risks their products presented to men’s health, including a potentially increased risk of heart attac
On July 6, 2015, GlaxoSmithKline (GKS), manufacturers of the anti-nausea drug Zofran, filed a motion requesting consolidation of all federal Zofran lawsuits. They stated that bringing all the cases together into one court would facilitate more efficient pre-trial proceedings, reduce the risk of inco
The FDA approved the anti-coagulant Xarelto (rivaroxaban) to reduce the risk of blood clots in patients going through knee and hip replacement surgery in 2011, and then later to reduce the risk of stroke in patients with non-valvular atrial fibrillation. Within just a year of…
Type 2 diabetes patients taking Invokana (canagliflozin) or other similar drugs to lower blood sugar may have an increased risk of yeast infections, as well as recurring infections, according to new research. Invokana has been previously linked to urinary tract infections and kidney problems, and…
On July 21, 2015, an Illinois couple filed a new Zofran birth defects lawsuit on behalf of their young son. They claim that the mother’s intake of Zofran during pregnancy caused the baby to suffer a congenital heart defect. The couple blames manufacturer GlaxoSmithKline (GSK)…
The Food and Drug Administration (FDA) approved Invokana (canagliflozin) for the treatment of type 2 diabetes in March 2013. After just a year on the market, the new drug was linked with 457 reports of adverse events, including serious side effects like kidney failure or…
Two new studies have raised additional concerns about Xarelto (rivaroxaban) excessive bleeding events. Both link the anticoagulant drug to serious risks of side effects that could result in hospitalization and even death. Xarelto was approved by the FDA in 2011 to reduce the risk of…
A New Jersey couple recently filed a new Zofran lawsuit, claiming that manufacturer GlaxoSmithKline (GSK) is liable for their child’s birth defects. This is one of many similar lawsuits pending in federal and state courts across the country. GSK recently filed a motion requesting consolidation…
